These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2832309)

  • 1. The characterization of equine herpes virus-1-infected cell polypeptides recognized by equine lymphocytes.
    Bridges CG; Ledger N; Edington N
    Immunology; 1988 Feb; 63(2):193-8. PubMed ID: 2832309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The proteins of equid herpesvirus 1 (EHV 1) recognised by equine antisera and their ability to promote antibody-dependent cell-mediated cytotoxicity.
    Bridges CG; Edington N
    Tierarztl Prax Suppl; 1987; 2():47-9. PubMed ID: 3035747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte responses to virus and mitogen in ponies during experimental infection with equine herpesvirus 1.
    Dutta SK; Myrup A; Bumgardner MK
    Am J Vet Res; 1980 Dec; 41(12):2066-8. PubMed ID: 6259978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
    Fitzpatrick DR; Studdert MJ
    Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to equine herpesvirus type 1 (rhinopneumonitis): in vitro lymphocyte response.
    Wilks CR; Coggins L
    Am J Vet Res; 1976 May; 37(5):486-92. PubMed ID: 179451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immunity during Equid herpesvirus 1 (EHV-1) infection.
    Bridges CG; Edington N
    Clin Exp Immunol; 1986 Jul; 65(1):172-81. PubMed ID: 2431815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of viral envelope proteins in equine herpesvirus 1-infected blood mononuclear cells during cell-associated viremia.
    van der Meulen K; Caij B; Pensaert M; Nauwynck H
    Vet Microbiol; 2006 Mar; 113(3-4):265-73. PubMed ID: 16387454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the major glycoproteins of equine herpesviruses 4 and 1 and asinine herpesvirus 3 using monoclonal antibodies.
    Crabb BS; Allen GP; Studdert MJ
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2075-82. PubMed ID: 1716650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro cytotoxicity of serum and peripheral blood leukocytes for equine herpesvirus type 1-infected target cells.
    Wilks CR
    Am J Vet Res; 1977 Jan; 38(1):117-21. PubMed ID: 189645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
    Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative studies of the proteins of equine herpesviruses 4 and 1 and asinine herpesvirus 3: antibody response of the natural hosts.
    Crabb BS; Studdert MJ
    J Gen Virol; 1990 Sep; 71 ( Pt 9)():2033-41. PubMed ID: 2170572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic and antigenic comparison of an equine herpesvirus 1 (EHV 1) isolate from the 1983 Lippizan abortion storm with EHV 1 reference strains.
    Engels M; Nowotny N; Metzler AE; Wyler R; Bürki F
    Microbiologica; 1986 Apr; 9(2):221-34. PubMed ID: 3012290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic restriction of cytolysis during equid herpesvirus 1 subtype 2 infection.
    Bridges CG; Edington N
    Clin Exp Immunol; 1987 Nov; 70(2):276-82. PubMed ID: 2827921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High molecular weight polypeptide bands specific for equine herpesvirus 4.
    Zheng M; Love DN; Sabine M
    Vet Microbiol; 1995 Sep; 46(1-3):203-11. PubMed ID: 8545957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune escape of equine herpesvirus 1 and other herpesviruses of veterinary importance.
    van der Meulen KM; Favoreel HW; Pensaert MB; Nauwynck HJ
    Vet Immunol Immunopathol; 2006 May; 111(1-2):31-40. PubMed ID: 16472872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of equine herpesvirus-1 antigens recognized by cytotoxic T lymphocytes.
    Soboll G; Whalley JM; Koen MT; Allen GP; Fraser DG; Macklin MD; Swain WF; Lunn DP
    J Gen Virol; 2003 Oct; 84(Pt 10):2625-2634. PubMed ID: 13679596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equine herpesvirus-1 infection induces IFN-gamma production by equine T lymphocyte subsets.
    Breathnach CC; Soboll G; Suresh M; Lunn DP
    Vet Immunol Immunopathol; 2005 Feb; 103(3-4):207-15. PubMed ID: 15621307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.